Reuters logo
2 months ago
BRIEF-Glenmark Pharmaceuticals gets tentative ANDA nod from U.S. FDA for saxagliptin tablets
June 14, 2017 / 4:37 AM / 2 months ago

BRIEF-Glenmark Pharmaceuticals gets tentative ANDA nod from U.S. FDA for saxagliptin tablets

June 14 (Reuters) - Glenmark Pharmaceuticals Ltd

* Says receives tentative ANDA approval for saxagliptin tablets, 2.5 mg and 5 mg Source text - (bit.ly/2sqOx3e) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below